№ lp_1_2_25266
File format: docx
Character count: 51218
File size: 1712 KB
This policy outlines guidelines for safe insulin prescribing, dispensing, administration, and monitoring for adults in the Trust, aligning with national healthcare standards.
Year:
2025
Region / City:
Tower Hamlets, Newham, Bedfordshire
Topic:
Diabetes care, insulin administration, healthcare policy
Document type:
Policy
Organization:
East London NHS Foundation Trust
Author:
Georgina Amparado Molina, Michael Asuma, Caroline Ogunsola
Target Audience:
Healthcare professionals, clinical staff
Effective period:
May 2025 – May 2028
Approval date:
14th May 2025
Date of last review:
May 2025
Date of next review:
May 2028
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2018
Region / City:
London
Topic:
Diabulimia, Integrated Diabetes and Mental Health Pathway
Document Type:
Response Template
Organization:
NHS England
Author:
Not specified
Target Audience:
Health providers, commissioners
Period of Implementation:
15 months
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2026
Organization:
Canberra Health Services
Department:
Neonatology
Document Type:
Procedure
Target Audience:
Medical Officers, Registered Nurses, Midwives, Student Nurses under supervision
Scope:
Neonates from birth to 44 weeks corrected gestational age
Related Policies:
Neonatal Intensive Care Drug Manual, ANMF guidelines
Definitions Included:
Blood Glucose Levels, Hyperglycaemia, Significant Hyperglycaemia
Treatment Recommendations:
Insulin infusion, glucose monitoring, TPN and enteral feeding guidance
Risks Addressed:
Hypoglycaemia, glucose delivery variability, insulin-plastic binding
Year:
2022
Region / City:
England
Topic:
Healthcare, Insulin Administration
Document Type:
Policy
Organization / Institution:
NHS England and Improvement (NHSEI)
Author:
Not specified
Target Audience:
Healthcare workers, support workers, non-regulated health and care roles, allied health professionals
Period of validity:
Not specified
Approval date:
November 2022
Date of changes:
Not specified
Year:
2022
Region / City:
ACT and surrounding NSW
Topic:
Paediatric Diabetes Care, Insulin Pump Therapy
Document Type:
Clinical Guideline
Organization:
Canberra Health Services (CHS)
Author:
Canberra Health Services, Paediatric Endocrinology and Diabetes Service
Target Audience:
Paediatric Diabetes Healthcare Providers
Period of Validity:
N/A
Approval Date:
N/A
Date of Last Revision:
N/A
Note:
Year
Region / city:
Canberra
Topic:
High-Risk Medicines, Insulin Administration
Document Type:
Procedure
Institution:
Canberra Health Services
Target Audience:
CHS Employees (Medical, Nursing, Midwifery, Pharmacy, Allied Health)
Year:
2026
Region / city:
Canberra
Topic:
Insulin infusion management in hospital settings
Document type:
Procedure
Organization / institution:
Canberra Health Services
Author:
Not specified
Target audience:
Medical officers, nurses, midwives, ICU/HDU/ED staff at North Canberra Hospital
Effective period:
Not specified
Approval date:
Not specified
Revision date:
Not specified
Version:
6
Issuing organisation:
Frimley Integrated Care System
Region:
Frimley ICS
Country:
United Kingdom
Document status:
Controlled document
Review date:
August 2025
Key topics:
Hybrid Closed Loop systems, insulin pump therapy, continuous glucose monitoring
Clinical area:
Paediatric type 1 diabetes
Target population:
Children and young people with type 1 diabetes
Relevant guidance:
NICE Technology Appraisal TA943
Care setting:
Specialist Diabetes Service
Multidisciplinary team involvement:
Yes
Implementation scope:
NHS England services
Document title:
Protocol for the adjustment of insulin doses in diabetes
Organisation:
Aneurin Bevan University Health Board
Service area:
Adult Diabetes Service
Type of document:
Clinical protocol
Target population:
Adults with diabetes
Clinical setting:
Acute and community settings
Intended users:
Diabetes dietitians within the multidisciplinary team
Author:
Elaine Hibbert-Jones
Contributors:
Francesca Annan; Dorothy Debrah; Neera Agarwal; Kathryn John
Responsible committee:
Medicines Management
Geographical scope:
Wales
Insulin preparations:
Aneurin Bevan Drug Formulary
Exclusions:
Inpatients; pregnancy; paediatrics; insulin pump therapy without additional training
Date issued:
May 2018
Review date:
May 2021
Key topics:
Insulin dose adjustment; hypoglycaemia; hyperglycaemia; blood glucose monitoring; basal and bolus insulin; injection technique
Year:
2025
Region / City:
Lancashire (North, Central and East Lancashire), Blackpool, Blackburn with Darwen, South Cumbria
Topic:
Insulin safety
Document Type:
Prescribing Alert
Organisation:
LSC ICB Medicines Safety Committee
Author:
NHS England
Target Audience:
Healthcare professionals
Period of Action:
Ongoing
Approval Date:
06.08.2025
Modification Date:
06.08.2025
Year:
2024
Region / City:
Global
Topic:
Insulin treatment in children and adolescents with diabetes
Document Type:
Clinical Practice Consensus Guidelines
Institution:
ISPAD
Authors:
Eda Cengiz, Thomas Danne, Tariq Ahmad, Ahila Ayyavoo, David Beran, Ethel Codner, Sarah Ehtisham, Przemyslawa Jarosz-Chobot, Lucy N. W. Mungai, Sze May Ng, Megan Paterson, Leena Priyambada
Target Audience:
Healthcare professionals involved in pediatric diabetes care
Period of Effect:
2024 and ongoing
Approval Date:
2024
Date of Changes:
2024
Keywords:
Type 1 diabetes, insulin, children, adolescents, intensive insulin therapy, diabetes complications
Description:
Clinical guidelines for insulin therapy in pediatric diabetes, focusing on updated insulin treatment regimens, including bolus and basal insulins, as well as new insulin analogs and devices for therapy.
Note:
Year
Topic:
Health
Document Type:
Procedural Guideline
Organization:
Plano Independent School District
Target Audience:
School health staff, nurses
Year:
2015
Region / city:
Global
Topic:
Acute hyperkalemia treatment
Document type:
Research review
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Healthcare professionals
Period of validity:
Not specified
Date of approval:
Not specified
Date of amendments:
Not specified
Conflict of Interests:
None
Clinical outcomes:
Potassium levels, ECG findings
Main intervention:
Intravenous calcium
Comparison:
No intervention, other interventions, placebo
Setting:
Adults
Background:
The acute treatment of hyperkalemia was reviewed in 2015.
Assessment:
Hyperkalemia is a common and life-threatening electrolyte imbalance.
Desirable effects:
Moderate effect of pharmacological intervention in mitigating hyperkalemia.
Undesirable effects:
Potential harm from calcium administration, especially in cardiac arrest patients.
Certainty of evidence:
Low certainty, based on limited observational data.
Values:
Primary outcome is ECG changes, with limited clinical relevant data.
Balance of effects:
Suggests against routine calcium use in cardiac arrest (weak recommendation).
Resources required:
Low cost of calcium.
Cost effectiveness:
No evidence of cost-effectiveness studies.
Equity:
No studies identified.
Acceptability:
Calcium has been recommended in international guidelines, but the new suggestion may face resistance.
Feasibility:
Feasible as a recommendation against routine use.
Context:
This document reviews evidence on the use of intravenous calcium for acute hyperkalemia treatment and recommends against its routine use in patients with hyperkalemia-induced cardiac arrest.
Population:
Paediatric patients in cardiac arrest suspected to be caused by hyperkalaemia
Intervention:
Insulin with glucose or salbutamol
Comparison:
No insulin with glucose and no salbutamol
Main outcomes:
Survival to discharge; Survival to discharge with favourable neurological outcome (PCPC 1–3 or no change from baseline); Survival to discharge with PCPC 1–2 or no change from baseline
Setting:
Any setting
Perspective:
Not specified
Conflict of interests:
None
Problem priority:
Varies
Desirable effects:
Small
Undesirable effects:
Trivial
Certainty of evidence:
No included studies
Values and preferences:
Probably no important uncertainty or variability
Balance of effects:
Probably favors the intervention
Resources required:
Varies
Certainty of evidence of required resources:
No included studies
Cost effectiveness:
No included studies
Equity impact:
Unknown
Acceptability:
Unknown
Feasibility:
Probably yes
Title:
Supplementary Information for Ethanol extract of Lentinus edodes exerted antioxidant activity in Caenorhabditis elegans by regulating insulin DAF-16 signaling pathway
Document Type:
Supplementary information
Section:
Materials and Methods
Research Topic:
Antioxidant activity and insulin DAF-16 signaling pathway
Biological Material:
Lentinus edodes
Model Organism:
Caenorhabditis elegans (N2)
Experimental Groups:
NFD, LEEE-L (0.1 mg/mL), LEEE-M (0.5 mg/mL), LEEE-H (1 mg/mL)
Extraction Method:
Ethanol extraction with ultrasonic treatment
In Vitro Assays:
DPPH, ABTS, hydroxyl radical scavenging assays
In Vivo Assays:
Heat stress assay, acute oxidative stress assay
Biochemical Indicators:
MDA, T-SOD, GSH-PX, CAT, ROS
Cell Analysis:
Apoptosis assay with acridine orange staining
Reagents and Kits:
Beyotime Biotechnology cell lysate; Jiancheng Bioengineering assay kits
Replication:
Three independent repeats per experiment
Geographical Reference:
Jinggangshan, China; Fuzhou, China; Shanghai, China; Nanjing, China
Storage Conditions:
-80°C freezer storage for extract
Year:
2023
Region / City:
KwaZulu Natal Province
Topic:
Sanitation Infrastructure Construction
Document Type:
Tender Document
Organization / Institution:
The Mvula Trust
Author:
The Mvula Trust
Target Audience:
Contractors, Bidders
Validity Period:
12 weeks
Approval Date:
15 September 2023
Amendment Date:
N/A
Project Number:
1
Cluster:
SAFE Batch 05
Bid Number:
TMT-DBE-23/24-SAFEB05-KZNCL17
Tender Closing Date:
02 October 2023
Contract Duration:
18 weeks
Tender Value:
VAT Inclusive
Type of Project:
VIP Sanitation
CIDB Grading:
5 GB or Higher
Contractor Requirements:
No Joint Venture / Consortium
Purpose:
Provision of sanitation facilities to schools
Year:
2022
Region / City:
United States
Theme:
Road safety, safe driving practices
Document Type:
Training guide
Organization / Institution:
National Highway Traffic Safety Administration
Author:
Not specified
Target Audience:
Drivers, especially commercial drivers
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2024
Region / City:
Toronto, ON
Subject:
Girl Guides of Canada Activity Participation
Document Type:
Permission Form
Organization:
Girl Guides of Canada
Author:
Girl Guides of Canada
Target Audience:
Parents/Guardians
Period of Activity:
May 24, 2024
Approval Date:
N/A
Modification Date:
N/A
Description:
A permission form for parents/guardians to authorize their child to participate in the Girl Guides of Canada event, GirlJam 2024, including risk acknowledgment and emergency contact information.
Year:
2010
Region / City:
Washington, DC
Theme:
Patient Safety, Healthcare Facilities
Document Type:
Directive
Institution:
Veterans Health Administration
Author:
Department of Veterans Affairs
Target Audience:
Healthcare professionals, facility administrators
Period of Action:
2010-2014
Approval Date:
June 28, 2010
Amendment Date:
Not specified